Medical News

RSS

Sciele Pharma files NDA for glycopyrrolate oral solution

Sciele Pharma, Inc., a Shionogi company, today announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for glycopyrrolate oral solution to treat chronic, moderate-to-severe drooling in pediatric patients. This condition often results from cerebral palsy as well as from other neurological disorders.

29 Sep 2009

Biomagnetics Diagnostics to develop handheld testing platform for malaria and bovine TB

Biomagnetics Diagnostics Corp., a producer of revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV and hepatitis testing today announced it has received a equity-based financing commitment up to $1 million from investors and an anonymous philanthropic source. These funds will be used to further develop the company’s unique handheld testing platform targeting the areas of malaria and bovine tuberculosis testing.

29 Sep 2009

Journal publishes Hythiam's PROMETA treatment program results

Hythiam, Inc. announced today that the results of a double-blind, placebo-controlled study on the impact of the medical component of the PROMETA® Treatment Program on alcohol dependent subjects was accepted and published in the Journal of Clinical Psychopharmacology, a leading scholarly publication in psychopharmacology that features articles reporting on clinical trials and studies.

29 Sep 2009

Oculus launches Microcyn Skin & Wound HydroGel OTC

Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.

29 Sep 2009

Benefits and harms of screening infants for hyperbilirubinemia still unclear

According to a new recommendation from the U.S. Preventive Services Task Force, there is insufficient evidence to assess the balance of benefits and harms of screening infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy. Hyperbilirubinemia is a condition marked by a high level of bilirubin in the blood, which is often apparent as yellow-colored skin and eyes (jaundice).

29 Sep 2009

ETH Zurich researchers develop biodegradable bone implants of metallic glass

It is possible that broken bones will in the near future be fixed using metallic glass. Materials researchers at ETH Zurich have developed an alloy that could herald a new generation of biodegradable bone implants. Their results have been published in the online edition of Nature Materials.

29 Sep 2009

Campaign of nonviolent civil disobedience to end insurance abuse

Citizens and health care providers who are fed up with the state of our health care system will risk arrest at a New York Aetna health insurance office on Tuesday morning. The sit-in is the first action in part of a larger mobilization to end insurance abuse and build support for real reform – Medicare for All, a single payer plan.

29 Sep 2009

New DataBlaster JT 37x7/PCIe boundary-scan controller from JTAG Technologies

JTAG Technologies, a leading provider of IEEE Std. 1149.1 solutions for testing and programming high-density PCBs, announces a further extension of its line of high-performance boundary-scan IEEE Std. 1149.1 controllers.

29 Sep 2009

Elan begins cash tender offer for $850 million in collective principal sum of 2011 Fixed Rate Notes

Elan Corporation, plc ("Elan") today announced that its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp., are commencing a cash tender offer (the “Tender Offer”) for the outstanding US$850 million in aggregate principal amount of their 7 3/4% senior fixed rate notes due 2011 (the “2011 Fixed Rate Notes”).

29 Sep 2009

Research finds novel chemical that targets drug-resistant bacteria

Eric Brown, a professor and chair of the Department of Biochemistry and Biomedical Sciences, and a team of researchers from the Michael G. DeGroote Institute for Infectious Disease Research have identified a novel chemical compound that targets drug-resistant bacteria in a different way from existing antibiotics. The discovery could lead to new treatments to overcome antibiotic resistance in certain types of microorganisms.

29 Sep 2009

Patheon's special meeting of shareholders to be held as announced on December 15, 2009

The Special Committee of Independent Directors of Patheon Inc. announced that Joaquin Viso and Olga Lizardi have agreed to adjourn on consent the previously disclosed Court application they commenced on September 2, 2009 seeking an order requiring that a special meeting of shareholders (the "Requisitioned Meeting") in response to their previously announced requisition be held no later than October 30, 2009.

29 Sep 2009

Also in Global Health news: News outlets explore AIDS vaccine research; chloroquine resistance unraveled; authorities contest maternal mortality report

The Associated Press examines the role of the Thai participants in the recent clinical trial of an experimental HIV vaccine which showed modest potential for preventing infection. "Nearly 16,000 Thais ignored the false rumors that they were being infected by the AIDS virus, and overcame their fears of becoming social outcasts to participate in trials of the first vaccine found to prevent infection with the deadly virus," the news service writes (Ahuja/Casey, 9/27).

29 Sep 2009

Smart Card Alliance: Cybersecurity and healthcare identity to be prioritized in upcoming year

The Smart Card Alliance Identity Council will turn its attention to cybersecurity and healthcare identity in the upcoming year, the Council said today, while continuing its work to educate and make identity credentialing recommendations for corporate enterprise, healthcare, state and local governments, and more. The Identity Council also announced new officers and steering committee, and plans to attend the Smart Card Alliance 8th Annual Smart Cards in Government Conference in Washington, DC.

29 Sep 2009

NHGRI and NIMH fund $45 million to establish Centers of Excellence in Genomic Science

The National Human Genome Research Institute (NHGRI) and National Institute of Mental Health (NIMH), both part of the National Institutes of Health, today announced grants expected to total approximately $45 million to establish new Centers of Excellence in Genomic Science at the Medical College of Wisconsin and University of North Carolina, Chapel Hill as well as to continue support of existing centers at Johns Hopkins University and the University of Southern California.

29 Sep 2009

NINDS: $50 billion spent each year for low back pain

A study by researchers at The George Institute for International Health in Australia found that it is rare for patients presenting to PCPs with acute lower back pain to have previously undiagnosed serious diseases. The most common serious disease cause documented was vertebral fracture, with half of the cases identified at the time of initial consultation.

29 Sep 2009

Baucus target of ad favoring a public option

Sen. Max Baucus, D-Mont., chairman of the Senate Finance Committee, is the target of an advertising campaign by two progressive groups advocating for the inclusion of a public option in legislation to overhaul the health care systeml, according to Capitol Briefing, a Washington Post blog.

29 Sep 2009

Lifeline Biotechnologies updates company's information on Pinks Sheets

Lifeline Biotechnologies, Inc. today announced that it has completed the updating of the Company’s information on Pinks Sheets.

29 Sep 2009

Changes to Louisiana's healthcare system can promote standardized care for patients

Before Hurricane Katrina, Louisiana's healthcare system was strained, with a quarter of the population living below the poverty line and an estimated 20 percent uninsured. Healthcare for this population was provided through the state-run Charity Hospital and financed through Medicaid DSH (Disproportionate Share Hospital) dollars.

29 Sep 2009

U.S. PTO to reexamine the patents in Cellectis-Precision BioSciences litigation

Precision BioSciences, Inc. today announced that the United States Patent and Trademark Office (PTO) has granted Precision’s requests for inter partes reexamination of U.S. Patent Nos. 6,610,545 (the ‘545 patent) and 7,309,605 (the ‘605 patent), which Cellectis SA (Alternext: ALCLS) has asserted against Precision in litigation.

29 Sep 2009

Scient’x launches its Isobar Evolution Dynamic Rod for treating lower lumbar spine pathologies

Scient’x Groupe S.A.S. (Scient’x) announces its focus on offering Dynamic Solutions for the spine. This corporate strategy positions Scient’x to be the worldwide leader in providing Dynamic Solutions for both non-fusion and fusion procedures.

29 Sep 2009

Medical News

Sciele Pharma files NDA for glycopyrrolate oral solution

Biomagnetics Diagnostics to develop handheld testing platform for malaria and bovine TB

Journal publishes Hythiam's PROMETA treatment program results

Oculus launches Microcyn Skin & Wound HydroGel OTC

Benefits and harms of screening infants for hyperbilirubinemia still unclear

ETH Zurich researchers develop biodegradable bone implants of metallic glass

Campaign of nonviolent civil disobedience to end insurance abuse

New DataBlaster JT 37x7/PCIe boundary-scan controller from JTAG Technologies

Elan begins cash tender offer for $850 million in collective principal sum of 2011 Fixed Rate Notes

Research finds novel chemical that targets drug-resistant bacteria

Patheon's special meeting of shareholders to be held as announced on December 15, 2009

Also in Global Health news: News outlets explore AIDS vaccine research; chloroquine resistance unraveled; authorities contest maternal mortality report

Smart Card Alliance: Cybersecurity and healthcare identity to be prioritized in upcoming year

NHGRI and NIMH fund $45 million to establish Centers of Excellence in Genomic Science

NINDS: $50 billion spent each year for low back pain

Baucus target of ad favoring a public option

Lifeline Biotechnologies updates company's information on Pinks Sheets

Changes to Louisiana's healthcare system can promote standardized care for patients

U.S. PTO to reexamine the patents in Cellectis-Precision BioSciences litigation

Scient’x launches its Isobar Evolution Dynamic Rod for treating lower lumbar spine pathologies

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News